January 2020 DAIT Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year 2021 Concepts

Fiscal Year 2022 Concepts

Fiscal Year 2021 Small Business Innovation Research (SBIR) Contract Solicitation Topics

Clinical Trials in Transplantation in Children and Adults

For the published request for applications, see the April 15, 2020 Guide announcement, Clinical Trials in Organ Transplantation in Children and Adults (CTOT-CA) (U01 Clinical Trial Optional).

Mucosal Immunology Studies Team (MIST)

For the published request for applications, see the April 24, 2020 Guide announcement, Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed).

Nonhuman Primate Reagent Resource

For the published request for applications, see the June 29, 2020 Guide announcement, Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed).

Allergy and Asthma Statistical and Coordinating Center

For the published request for proposals, see the August 20, 2020 solicitation, Allergy and Asthma Statistical and Clinical Coordinating Center.

Transplantation Statistical and Coordinating Center

For the published request for proposals, see the August 20, 2020 solicitation, Transplantation Statistical & Clinical Coordinating Center (T-SCCC).

Autoimmune Diseases Statistical and Coordinating Center

For the published request for proposals, see the August 27, 2020 solicitation, Autoimmune Diseases Statistical and Clinical Coordinating Center.

Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases

For the published request for proposals, see the July 28, 2020 Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals.

Adjuvant Discovery for Vaccines and for Autoimmune and Allergic Diseases

For the published request for proposals, see the July 28, 2020 Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals.

Production of Adjuvants Mimics

For the published request for proposals, see the July 28, 2020 Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals.

Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models

For the published request for proposals, see the July 28, 2020 Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals.

Content last reviewed on